Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent
Marco Jost, Yuwen Chen, Luke A. Gilbert, et al.
Molecular Cell (2017) Vol. 68, Iss. 1, pp. 210-223.e6
Open Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

Pervasive functional translation of noncanonical human open reading frames
Jin Chen, Andreas‐David Brunner, J. Zachery Cogan, et al.
Science (2020) Vol. 367, Iss. 6482, pp. 1140-1146
Open Access | Times Cited: 530
Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton
Michel O. Steinmetz, A.E. Prota
Trends in Cell Biology (2018) Vol. 28, Iss. 10, pp. 776-792
Closed Access | Times Cited: 395
Targeting the MAPK Pathway in KRAS-Driven Tumors
Matthias Drosten, Mariano Barbacid
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 543-550
Open Access | Times Cited: 382
Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq
Joseph M. Replogle, Reuben A. Saunders, Angela N. Pogson, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2559-2575.e28
Open Access | Times Cited: 363
Therapeutic strategies to target RAS-mutant cancers
Meagan B. Ryan, Ryan B. Corcoran
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 11, pp. 709-720
Closed Access | Times Cited: 340
CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine
Martin Kampmann
ACS Chemical Biology (2017) Vol. 13, Iss. 2, pp. 406-416
Open Access | Times Cited: 313
A CRISPR–dCas Toolbox for Genetic Engineering and Synthetic Biology
Xiaoshu Xu, Lei S. Qi
Journal of Molecular Biology (2018) Vol. 431, Iss. 1, pp. 34-47
Open Access | Times Cited: 283
Massively multiplex chemical transcriptomics at single-cell resolution
Sanjay Srivatsan, José L. McFaline‐Figueroa, Vijay Ramani, et al.
Science (2019) Vol. 367, Iss. 6473, pp. 45-51
Open Access | Times Cited: 283
Advances in targeting ‘undruggable’ transcription factors with small molecules
Matthew J. Henley, Angela N. Koehler
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 669-688
Closed Access | Times Cited: 264
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts
Jeffrey J. Quinn, Matthew G. Jones, Ross A. Okimoto, et al.
Science (2021) Vol. 371, Iss. 6532
Open Access | Times Cited: 238
High-Throughput Screening: today’s biochemical and cell-based approaches
Vincent Blay, Bhairavi Tolani, Sunita P. Ho, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 10, pp. 1807-1821
Closed Access | Times Cited: 237
Enabling genetic analysis of diverse bacteria with Mobile-CRISPRi
Jason M. Peters, Byoung‐Mo Koo, Ramiro Patino, et al.
Nature Microbiology (2018) Vol. 4, Iss. 2, pp. 244-250
Open Access | Times Cited: 231
Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships
Damian R. Plichta, Daniel B. Graham, Sathish Subramanian, et al.
Cell (2019) Vol. 178, Iss. 5, pp. 1041-1056
Open Access | Times Cited: 217
A new era in functional genomics screens
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 183
Identifying chemogenetic interactions from CRISPR screens with drugZ
Medina Colic, Gang Wang, Michal Zimmermann, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 182
Ras and Rap1: A tale of two GTPases
Seema Shah, Ethan J. Brock, Kyungmin Ji, et al.
Seminars in Cancer Biology (2018) Vol. 54, pp. 29-39
Open Access | Times Cited: 171
Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
Huimin Zhang, Chunhong Qin, Changming An, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 170
Mapping the genetic landscape of DNA double-strand break repair
Jeffrey A. Hussmann, Ling Jia, Purnima Ravisankar, et al.
Cell (2021) Vol. 184, Iss. 22, pp. 5653-5669.e25
Open Access | Times Cited: 141
Polo-like kinase 1 (PLK1) signaling in cancer and beyond
Styliani Iliaki, Rudi Beyaert, Inna S. Afonina
Biochemical Pharmacology (2021) Vol. 193, pp. 114747-114747
Closed Access | Times Cited: 133
A compendium of kinetic modulatory profiles identifies ferroptosis regulators
Megan Conlon, Carson Poltorack, Giovanni C. Forcina, et al.
Nature Chemical Biology (2021) Vol. 17, Iss. 6, pp. 665-674
Open Access | Times Cited: 118
MTCH2 is a mitochondrial outer membrane protein insertase
Alina Guna, Taylor A. Stevens, Alison J. Inglis, et al.
Science (2022) Vol. 378, Iss. 6617, pp. 317-322
Open Access | Times Cited: 96
CRISPR-based functional genomics for neurological disease
Martin Kampmann
Nature Reviews Neurology (2020) Vol. 16, Iss. 9, pp. 465-480
Open Access | Times Cited: 131
A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity
Adam C. Palmer, Christopher Chidley, Peter K. Sorger
eLife (2019) Vol. 8
Open Access | Times Cited: 114
Inference of single-cell phylogenies from lineage tracing data using Cassiopeia
Matthew G. Jones, Alex Khodaverdian, Jeffrey J. Quinn, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 105
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
Shuai Wen, Guan Wang, Yiwen Zhang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7963-7990
Closed Access | Times Cited: 101
Page 1 - Next Page

Scroll to top